Genetic Variations in DNA Methyltransferases and Breast Cancer Risk in Arkansas Women

Overview

This nested case-control study within the Arkansas Rural Community Health (ARCH) cohort analyzed SNPs in DNMT1, DNMT3A, and DNMT3B genes among 967 breast cancer cases and 1440 controls. The study identified associations between specific genetic polymorphisms and breast cancer susceptibility, highlighting the role of DNA methyltransferase genetic variation in breast cancer risk.

Background

Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer-related death among women in the United States, with about one in eight women affected during their lifetime. Despite advances in early detection and treatment, incidence rates have modestly increased, and approximately half of breast cancer cases occur without known risk factors beyond age and sex. Epigenetic modifications, particularly DNA methylation regulated by DNA methyltransferases (DNMTs), play a critical role in gene expression and genomic stability. Genetic polymorphisms in DNMT genes may influence breast cancer susceptibility, but prior studies have been limited and population-specific.

Data Highlights

Key Findings

• Analysis included 967 breast cancer cases and 1440 controls from the ARCH cohort after exclusions for incomplete data.
• Genotyping of DNMT1, DNMT3A, and DNMT3B SNPs was performed using TaqMan assays with high call rates ensuring data quality.
• Haplotype analysis was employed to assess combined effects of SNP clusters rather than single SNP associations.
• Specific SNPs in DNMT genes showed associations with breast cancer risk, supporting the role of epigenetic regulation in cancer susceptibility.
• The study population reflects a rural and socioeconomically diverse cohort, addressing gaps in prior research focused on other ethnic groups.

Clinical Implications

Understanding genetic variations in DNA methyltransferases can improve risk stratification for breast cancer, particularly in rural and diverse populations. These findings may inform precision medicine approaches by identifying individuals with genetic susceptibility related to epigenetic regulation. Further research could explore targeted prevention or therapeutic strategies based on DNMT genetic profiles.

Conclusion

This study demonstrates that genetic polymorphisms in DNMT genes are associated with breast cancer risk in a rural Arkansas population, underscoring the importance of epigenetic mechanisms in breast cancer etiology. These insights contribute to the broader understanding of genetic and epigenetic factors influencing cancer susceptibility.

References

1. Arkansas Rural Community Health Study (ARCH) -- Cohort Description and Methods
2. World Health Organization -- Breast Cancer Epidemiology
3. Thermo Fisher Scientific -- TaqMan SNP Genotyping Assays
4. Prior Studies on DNMT SNPs and Breast Cancer Risk -- British and Han Chinese Populations